- Home
- WGS
WGS
GeneDx Holdings Corp.
as 04-18-2025 1:45pm EST
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | STAMFORD |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $82.60 | AVG Volume (30 days): | 792.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.63 - $115.60 | Next Earning Date: | 04-30-2025 |
| Revenue: | $305,450,000 | Revenue Growth: | 50.79% |
| Revenue Growth (this year): | 18.58% | Revenue Growth (next year): | 17.65% |
Latest GeneDx Holdings Corp. News
WGS Breaking Stock News: Dive into WGS Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand
Medical Device Network
2 days ago
GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition
Investor's Business Daily
3 days ago
IBD 50's GeneDx Inks $51 Million AI-Tied Takeover Deal
MT Newswires
3 days ago
GeneDx to Acquire Fabric Genomics for Up to $51 Million
Business Wire
3 days ago
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
Business Wire
11 days ago
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
Business Wire
16 days ago
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
Zacks
17 days ago
Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff Threats
Compare WGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WGS GeneDx Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.